Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

As our understanding on coronavirus disease 2019 (COVID-19) deepens, it is increasingly
recognized that COVID-19 is more than a respiratory condition. Thrombocytopenia and …

The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …

Introduction COVID-19 associated VTE is a new disease entity with high morbidity and
mortality. The aim of this paper is to review contemporary emerging literature on the …

Abstract Infection with SARS-CoV-2 (COVID-19) can cause prothrombotic complications. We
aim to study the frequency of thrombotic complications and impact of anticoagulation on …

The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also
known as COVID-19, is a single-stranded enveloped RNA virus that created a Public Health …

Patients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early
reports describe high venous thromboembolism (VTE) and disseminated intravascular …

Background Several observational studies have reported the rate of venous and arterial
thrombotic events in patients infected with COVID-19, with conflicting results. The aim of this …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …